Mabpharm Limited

Mabpharm Limitedverified

2181.HK

Price:

$0.6

Market Cap:

$2.25B

Mabpharm Limited, a biopharmaceutical company, engages in research, development, and production of drugs and biosimilar drugs for allergic diseases, cancers, and autoimmune diseases in China. Its products under the Phase III clinical trial include CMAB007, a recombinant humanized anti-IgE monoclonal antibody for treatment of asthma patients; CMAB009, a recombinant anti-EGFR chimeric monoclonal antibody for the first-line treatment of metastatic colorectal cancer; CMAB008, a recombinant anti-TNF-alpha chimeric monoclonal antibody for moderate to severe active rheumatoid arthritis; and CMAB807 for osteoporosis indications. The company is also developing CMAB819 that is in Phase I clinical tria...[Read more]

Industry

Biotechnology

IPO Date

2019-05-31

Stock Exchange

HKSE

Ticker

2181.HK

The Enterprise Value as of December 2025 (TTM) for Mabpharm Limited (2181.HK) is 2.46B

According to Mabpharm Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 2.46B. This represents a change of 55.23% compared to the average of 1.58B of the last 4 quarters.

Mabpharm Limited (2181.HK) Historical Enterprise Value (quarterly & annually)

How has 2181.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Mabpharm Limited over the last ten years is 2.89B. The current 2.46B Enterprise Value has changed 8.39% with respect to the historical average. Over the past ten years (40 quarters), 2181.HK's Enterprise Value was at its highest in in the June 2020 quarter at 4.40B. The Enterprise Value was at its lowest in in the January 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

2.89B

Median

3.26B

Minimum

1.29B

Maximum

4.29B

Mabpharm Limited (2181.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mabpharm Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 7.68%

Maximum Annual Enterprise Value = 4.29B

Minimum Annual Increase = -49.53%

Minimum Annual Enterprise Value = 1.29B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20241.29B-28.65%
20231.81B7.68%
20221.68B-49.53%
20213.32B3.88%
20203.20B-6.55%
20193.42B-20.14%
20184.29B3.23%

Mabpharm Limited (2181.HK) Average Enterprise Value

How has 2181.HK Enterprise Value performed in the past?

The current Enterprise Value of Mabpharm Limited (2181.HK) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

1.59B

5-year avg

2.26B

10-year avg

2.89B

Mabpharm Limited (2181.HK) Enterprise Value vs. Peers

How is 2181.HK’s Enterprise Value compared to its peers?

Mabpharm Limited’s Enterprise Value is greater than SinoMab BioScience Limited (1.96B), greater than HighTide Therapeutics Inc (1.44B), greater than Shanghai Bio-heart Biological Technology Co., Ltd. (1.17B), greater than Cutia Therapeutics (1.85B), greater than Immunotech Biopharm Ltd (1.55B), greater than Frontage Holdings Corporation (372.33M), greater than JW (Cayman) Therapeutics Co. Ltd (886.52M), greater than Zhaoke Ophthalmology Limited (781.77M), greater than 3D Medicines Inc. (1.23B), greater than Genor Biopharma Holdings Limited (764.43M),

Build a custom stock screener for Mabpharm Limited (2181.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mabpharm Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mabpharm Limited (2181.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mabpharm Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Mabpharm Limited's Enterprise Value?

What is the highest Enterprise Value for Mabpharm Limited (2181.HK)?

What is the 3-year average Enterprise Value for Mabpharm Limited (2181.HK)?

What is the 5-year average Enterprise Value for Mabpharm Limited (2181.HK)?

How does the current Enterprise Value for Mabpharm Limited (2181.HK) compare to its historical average?